Completed × Prostatic Neoplasms × Other hematologic neoplasm × Clear all EARN
Phase NA Completed
33 enrolled
Lighting Intervention for Cancer-related Fatigue
Phase NA Completed
139 enrolled 13 charts
IIT2020-20-SHIRAZIP-WALK: Nature Walks
Phase NA Completed
20 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
Phase 1 Completed
118 enrolled
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Completed
55 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
Analyses of Human Samples Collected in Clinical Trials
Completed
2,579 enrolled
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
PREDICARE
Completed
420 enrolled
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
Phase 1 Completed
128 enrolled
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer
Phase 1 Completed
36 enrolled
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Phase NA Completed
325 enrolled
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Phase NA Completed
322 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Phase 1 Completed
180 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Flavopiridol in Treating Patients With Refractory Cancer
Phase 1 Completed
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Phase 1 Completed
113 enrolled
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
Phase 1 Completed
64 enrolled
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Phase 1 Completed
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
Phase 2 Completed
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Phase 1 Completed
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Phase 1 Completed
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Phase 2 Completed
585 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled